Coast-to-coast compassion for those living with an

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
844
Coast-to-coast compassion for those living with an invisible illness

TORONTO, June 06, 2018 (GLOBE NEWSWIRE) -- Over 20,000 Canadians from across the country united at the Gutsy Walk on Sunday, June 3 to raise awareness and funds for Crohn’s and colitis, chronic inflammatory bowel diseases that often go unseen.

“People who live with Crohn’s or colitis may have a hard time opening up about living with their disease,” said Mina Mawani, President and CEO of Crohn’s and Colitis Canada. “When you’re constantly dealing with pain, fatigue, and repeated washroom trips, and when those symptoms aren’t always evident to others, it’s not easy to talk about.”

By being a part of the Gutsy Walk, participants created welcoming and understanding environments for the people in their communities affected by Crohn’s or colitis. Funds raised through the walk will support Crohn’s and Colitis Canada’s research projects and patient support programs.

“It’s so important that people affected by Crohn’s or colitis know they’re not alone,” said 14-year-old Matthew O’Halloran, who lives with Crohn’s disease and is the 2018 Gutsy Walk National Honorary Chair. “When I see people making connections at the Gutsy Walk, I know that we’re creating more understanding about the diseases, and giving hope that people can live well in spite of them.”

Donations to the Gutsy Walk will be accepted until July 5, 2018, and can be made at www.gutsywalk.ca .

About Crohn’s Disease and Ulcerative Colitis

Crohn’s disease and ulcerative colitis – the two main forms of inflammatory bowel disease (IBD) – are autoimmune diseases that cause the body to attack healthy tissue, leading to the inflammation of all or part of the gastrointestinal tract. Symptoms include abdominal pain, cramping, fatigue, internal bleeding, and frequent and urgent bowel movements, in some cases over 20 times a day. Canada has some of the highest incidence rates of Crohn’s and colitis in the world, with approximately 250,000 people diagnosed. One Canadian is newly diagnosed with Crohn’s or colitis every hour.

About Crohn’s and Colitis Canada

Crohn’s and Colitis Canada is the only national, volunteer-based charity focused on finding the cures for Crohn’s disease and ulcerative colitis and improving the lives of children and adults affected by these diseases. We are one of the top two health charity funders of Crohn’s and colitis research in the world, investing over $115 million in research to date. We are transforming the lives of people affected by Crohn’s and colitis (the two main forms of inflammatory bowel disease) through research, patient programs, advocacy, and awareness.

For more information or to arrange an interview, please contact:

Rasheed Clarke Marketing and Communications Specialist Crohn’s and Colitis Canada 416-920-5035 x 215 rclarke@crohnsandcolitis.ca

Nic Canning Account Manager Smithcom Ltd. 413-992-7187 nic.canning@smithcom.ca

Photos accompanying this announcement are available at

http://www.globenewswire.com/NewsRoom/Attachm...ea1cd85de5

http://www.globenewswire.com/NewsRoom/Attachm...68bf26dc7b

http://www.globenewswire.com/NewsRoom/Attachm...3880c0d64f

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Faith and Resilience in China: The Legacy of the Long March

Updated Category News Views 20

History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...

Continue Reading
Antheia Secures $80M for Critical Medicine Onshoring

Updated Category News Views 22

Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...

Continue Reading
AEVEX Faces 48-Hour Deadline for Investor Class Action

Updated Category News Views 16

Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....

Continue Reading
Lundbeck's Board Leadership Transitions into New Era

Updated Category News Views 10

A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...

Continue Reading
Tomorrowland's Shanghai Return: An Electri-Lifesaver

Updated Category News Views 25

You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...

Continue Reading
ASTS Faces a Legal Countdown – Investors Take Note

Updated Category News Views 11

AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...

Continue Reading
UEG's New Advisory Board: Elevating Patient Voices

Updated Category News Views 21

Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...

Continue Reading

Top 5 Most Recently Viewed Articles

Thermo Fisher's Role as the Leading Partner in Biopharma

Updated Category News Views 212

Thermo Fisher's Role in Revolutionizing Biopharma Thermo Fisher Scientific Inc. (TMO) is increasingly becoming the cornerstone of the biopharma sector. Although some analysts have observed a recent dip in its stock performance, there is a strong belief in its capability to rebound through strategic acquisitions and promising growth prospects. Notably, Thermo Fisher boasts...

Continue Reading
Jamf Unveils Comprehensive Reinvestment Strategy for Growth

Updated Category News Views 161

Jamf's Strategic Reinvestment Initiative In a bold move aimed at enhancing operational efficiency and shareholder value, Jamf (NASDAQ: JAMF) has announced a strategic reinvestment plan designed to propel long-term growth. This initiative comes on the heels of a comprehensive systems update that has illuminated new business opportunities and operational insights. Enhancing...

Continue Reading
Fidelity D & D Bancorp, Inc. Sees Earnings Impact in Q3

Updated Category News Views 46

Fidelity D & D Bancorp, Inc. Announcements on Financial Standing In recent news regarding Fidelity D & D Bancorp, Inc. (NASDAQ: FDBC), the company revealed its latest financial results, marking a significant quarter in their ongoing operations. As of September 30, 2024, Fidelity Bank, under the leadership of President and CEO Daniel J. Santaniello, has recorded key...

Continue Reading
Deutsche Bank Lowers Boeing Price Target, Retains Buy Rating

Updated Category News Views 71

Deutsche Bank's Strategic Assessment of Boeing Recently, Deutsche Bank has made headlines with its updated financial outlook for Boeing (NYSE: BA), decreasing the stock price target from $225.00 to $195.00. However, they have maintained a Buy rating on the aerospace company's shares. This adjustment comes in response to expected larger free cash flow (FCF) burn for the...

Continue Reading
TIGRIS Aquatic Services Expands With LakePro Acquisition

Updated Category News Views 868

TIGRIS Aquatic Services Expands With LakePro Acquisition TIGRIS Aquatic Services, LLC has made a significant move by acquiring LakePro, Inc., a prominent player in the field of aquatic management. This acquisition opens new opportunities for TIGRIS, expanding its operational reach into fresh markets and reinforcing its commitment to creating safe and well-managed water...

Continue Reading